Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02803593 · ClinicalTrials.gov registry record · NA
To Enhance Breast Cancer Survivorship of Asian Americans
A NA study of Breast Cancer, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 199
- Enrollment target
- 2
- Study locations
NCT02803593: Completed NA study of Breast Cancer, sponsored by Emory University.
NCT02803593 is a NA study of Breast Cancer that has completed, run by Emory University. The registered enrollment target is 199 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02803593, a NA study of Breast Cancer, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this randomized intervention study is to test the efficacy of the technology-based information and coaching/support program for Asian American breast cancer survivors (TICAA) in enhancing the women's breast cancer survivorship experience.
Primary Outcome
The SCNS uses 57 items to measure how much help the respondent needs. Responses are given on a scale from 1 to 5 where 1 = no help is needed and 5 = high need for help. Total scores range from 57 to 285 and higher scores indicate greater need for help.
Conditions Studied
Interventions
- BEHAVIORAL Technology-based information and coaching/support program
- BEHAVIORAL American Cancer Society information on breast cancer
Study Locations (2)
Georgia
- Emory University Hospital - Atlanta
North Carolina
- Duke University, School of Nursing - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2016-06 |
| Est. Completion | 2021-06-09 |
| Phase | NA |
What the finished NCT02803593 record still lists
NCT02803593 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Technology-based information and coaching/support program is the first listed.
NCT02803593 reports a single indexed study location in Georgia, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02803593 about?
NCT02803593 is a clinical study titled "To Enhance Breast Cancer Survivorship of Asian Americans". The purpose of this randomized intervention study is to test the efficacy of the technology-based information and coaching/support program for Asian American breast cancer survivors (TICAA) in enhancing the women's breast cancer survivorship experience.
What is the current status of trial NCT02803593?
This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2016-06. Estimated completion is 2021-06-09.
What conditions does trial NCT02803593 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02803593?
The interventions under investigation include: Technology-based information and coaching/support program (BEHAVIORAL), American Cancer Society information on breast cancer (BEHAVIORAL).
Who is sponsoring clinical trial NCT02803593?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02803593 being conducted?
This trial has 2 study locations across Georgia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02803593's enrollment target sits among peer trials
199 385th of 1224 higher than 840 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia